XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total Stryker shareholders' equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of accounting changes         $ (759)    
Beginning balance at Dec. 31, 2017     $ 37 $ 1,496 8,986 $ (553) $ 14
Beginning balance (in shares) at Dec. 31, 2017     374.4        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock option and benefit plans       (32)      
Issuance of common stock under stock option and benefit plans (in shares)     1.2        
Repurchase of common stock       (7) (293)    
Repurchase of common stock (in shares)     (1.9)        
Share-based compensation       29      
Net earnings (loss) $ 443       443   0
Cash dividends declared         (176)    
Other comprehensive income (loss) 43         43  
Interest purchased             (6)
Ending balance at Mar. 31, 2018 9,223 $ 9,214 $ 37 1,486 8,201 (510) 9
Ending balance (in shares) at Mar. 31, 2018     373.7        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency exchange translation adjustment             1
Cumulative effect of accounting changes         0    
Beginning balance at Dec. 31, 2018 11,730   $ 37 1,559 10,765 (631) 0
Beginning balance (in shares) at Dec. 31, 2018     374.4        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock option and benefit plans     $ 0 (48)      
Issuance of common stock under stock option and benefit plans (in shares)     1.3        
Repurchase of common stock     $ 0 (8) (299)    
Repurchase of common stock (in shares)     (1.9)        
Share-based compensation       35      
Net earnings (loss) 412       412   0
Cash dividends declared         (195)    
Other comprehensive income (loss) 66         66  
Interest purchased             0
Ending balance at Mar. 31, 2019 $ 11,693 $ 11,693 $ 37 $ 1,538 $ 10,683 $ (565) 0
Ending balance (in shares) at Mar. 31, 2019     373.8        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency exchange translation adjustment             $ 0